What is the current somatic genetic testing market size?

The somatic genetic testing market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the somatic genetic testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by key drivers.

What are the key drivers of the somatic genetic testing market?

Key drivers include increasing cancer incidence and advancements in genetic testing technologies.

What are the major challenges facing the somatic genetic testing market?

Challenges include high costs, regulatory hurdles, and limited awareness of genetic testing.

Which regions are expected to lead the somatic genetic testing market?

North America and Europe are expected to be regional leaders due to high adoption rates.

Who are the top companies in the somatic genetic testing market?

Top companies include Illumina, Thermo Fisher, and Roche, offering a range of genetic testing solutions.

What future opportunities exist in the somatic genetic testing market?

Future opportunities include emerging markets, innovative technologies, and increasing demand for personalized medicine.

How will technology impact the somatic genetic testing market?

Advances in technologies like next-generation sequencing will drive growth and improve testing accuracy.

What is the current regulatory landscape for the somatic genetic testing market?

The regulatory landscape is evolving, with increasing focus on standardization and accreditation of genetic testing labs.

What is the future outlook for the somatic genetic testing market?

The future outlook is positive, with growing demand for genetic testing and increasing adoption of precision medicine approaches.

somatic genetic testing Market: Opportunity by 2034 | In-Depth Report

somatic genetic testing by Application (Academic and Research Institutions, Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others), by Types (Product (Kits and Assays, Instruments, and Software), Services) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

somatic genetic testing Market Overview

The somatic genetic testing market refers to the industry involved in the analysis of genetic mutations that occur in non-hereditary cells, providing crucial insights for disease diagnosis and treatment. As the somatic genetic testing market size is expected to reach $4.8 billion by 2026, the growth outlook appears promising, with a market forecast indicating a compound annual growth rate (CAGR) of 12.1% during the forecast period. The industry expansion is primarily driven by the increasing adoption of genetic testing in cancer diagnosis and treatment, as well as the growing demand for personalized medicine. The scope of the market encompasses various types of genetic tests, including next-generation sequencing, polymerase chain reaction, and microarray analysis, which are applied in different end-use sectors such as hospitals, research institutions, and pharmaceutical companies.

Loading chart…

The somatic genetic testing market is expected to be shaped by key forces such as technology shifts, including the development of new genetic testing technologies, regulations, such as the increasing need for standardization and quality control, and consumer behavior, including the growing demand for personalized medicine. The largest region in the market is expected to be North America, while the fastest-growing region is anticipated to be the Asia-Pacific. The growth forecast indicates a promising outlook for the market, driven by the increasing adoption of genetic testing in disease diagnosis and treatment, as well as the growing demand for personalized medicine. As the market continues to evolve, it is likely to be influenced by various factors, including competitive intensity, supply-chain dynamics, and macro drivers, such as the increasing prevalence of genetic disorders and the growing need for targeted therapies.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	37.22 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Agilent Technologies, Inc.; ARUP Laboratories; ASURAGEN INC; Beijing Genomics Institute (BGI) Genomics Co.,Ltd; bioMérieux S.A.; CENTOGENE N.V; CIRCULOGENE Theranostics, LLC; F. Hoffmann-La Roche Ltd.; Guardant Health, Inc.; Illumina, Inc.; Invivoscribe, Inc.; Laboratory Corporation of America Holdings; Mission Bio; NeoGenomics Laboratories, Inc.; OmniSeq; Oxford Nanopore Technologies, Ltd.; Pacific Biosciences of California, Inc.; QIAGEN N.V.; Quest Diagnostics Incorporated; Thermo Fisher Scientific Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The somatic genetic testing market is poised for significant growth, driven by advancements in technology and increasing demand for personalized medicine. This section outlines the key dynamics shaping the market, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Advances in next-generation sequencing (NGS) technologies have improved the accuracy and speed of somatic genetic testing, enabling the detection of rare genetic mutations and driving growth in the somatic genetic testing market size.

The rising incidence of cancer and other genetic disorders has created a surge in demand for somatic genetic testing, with the global growth forecast indicating a significant increase in adoption rates over the next five years.

Restraints2 items

High costs associated with somatic genetic testing and the need for specialized equipment and expertise are limiting factors in the market, affecting the somatic genetic testing market size and hindering widespread adoption.

Stringent regulatory requirements and the need for standardized testing protocols are also constraining the growth of the somatic genetic testing market, as companies must navigate complex frameworks to ensure compliance.

Opportunities2 items

The increasing use of liquid biopsies and other non-invasive sampling methods is creating new opportunities for somatic genetic testing, enabling the detection of genetic mutations in circulating tumor DNA and expanding the market's potential.

The growing demand for personalized medicine and targeted therapies is driving the adoption of somatic genetic testing, as healthcare providers seek to tailor treatment strategies to individual patients' genetic profiles, further fueling the growth forecast.

Challenges2 items

The interpretation of complex genetic data and the need for specialized expertise in bioinformatics and genomics are significant challenges in the somatic genetic testing market, requiring significant investment in training and resources.

Ensuring the privacy and security of genetic data is also a major concern, as the somatic genetic testing market must navigate the risks associated with sensitive patient information and maintain public trust.

Market Segmentation

Loading chart…

The somatic genetic testing market can be segmented based on application, which includes various fields such as oncology, neurology, and cardiology. Each application contributes to the overall somatic genetic testing market size, with oncology being the largest segment. This is due to the increasing incidence of cancer and the growing demand for genetic testing to diagnose and treat the disease. The somatic genetic testing segmentation by application is crucial in understanding the market trends and opportunities.

Another way to segment the somatic genetic testing market is by types, which includes single nucleotide polymorphism (SNP) genotyping, copy number variation (CNV) analysis, and loss of heterozygosity (LOH) analysis. Each type has its own set of applications and contributes to the overall market size. For instance, SNP genotyping is widely used in oncology to identify genetic mutations associated with cancer. Understanding the market taxonomy of somatic genetic testing by types is essential for companies to develop targeted products and services.

somatic genetic testing Segmentation Breakdown9 items

Application

Academic and Research Institutions

Hospitals and Diagnostic Laboratories

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Others

Types

Product (Kits and Assays, Instruments, and Software)

Services

Regional Insights

Loading chart…

The somatic genetic testing market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The Asia Pacific region is anticipated to be the fastest-growing region, driven by increasing adoption of genetic testing, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics and ecosystem maturity; for Europe, policies and infrastructure; for Asia Pacific, adoption and investments; for Latin America, infrastructure and ecosystem maturity; and for Middle East & Africa, policies and demographics.

The regional forecast indicates that the Asia Pacific region will experience significant somatic genetic testing market growth, driven by the increasing demand for genetic testing and the growing ecosystem maturity. In contrast, the Middle East & Africa region is expected to have a relatively lower share, due to limited infrastructure and adoption.

Competitive Landscape

The somatic genetic testing market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The somatic genetic testing competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Global players tend to have an advantage in terms of economies of scale and brand recognition, while local companies focus on regional expertise and customized solutions.

Companies in the somatic genetic testing market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. However, they face challenges like margin pressure, compliance costs, and commoditization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Agilent Technologies, Inc. - regional expansion

ARUP Laboratories - vertical integration

ASURAGEN INC - premium pricing

Beijing Genomics Institute (BGI) - innovation pipeline

bioMérieux S.A. - local manufacturing

CENTOGENE N.V - OEM tie-ups

Key somatic genetic testing Companies20 items

Agilent Technologies, Inc.

ARUP Laboratories

ASURAGEN INC

Beijing Genomics Institute (BGI) Genomics Co.,Ltd

bioMérieux S.A.

CENTOGENE N.V

CIRCULOGENE Theranostics, LLC

F. Hoffmann-La Roche Ltd.

Guardant Health, Inc.

Illumina, Inc.

Invivoscribe, Inc.

Laboratory Corporation of America Holdings

Mission Bio

NeoGenomics Laboratories, Inc.

OmniSeq

Oxford Nanopore Technologies, Ltd.

Pacific Biosciences of California, Inc.

QIAGEN N.V.

Quest Diagnostics Incorporated

Thermo Fisher Scientific Inc.

Market Ecosystem

The somatic genetic testing ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three key stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers create testing products; and downstream, where channels and end users interact. The value chain analysis of this ecosystem reveals how value is created and captured at each stage, influencing the overall efficiency and effectiveness of somatic genetic testing.

Raw material suppliers — providing genetic testing reagents

Technology providers — developing genetic testing platforms

OEMs/manufacturers — producing testing equipment and kits

System integrators — configuring testing systems for laboratories

Distributors/channel partners — supplying testing products to end users

Service providers — offering testing and analysis services

Regulators/standards bodies — establishing testing standards and guidelines

The flow of value within the somatic genetic testing ecosystem is influenced by various control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption rates. Dependency risks, including input constraints and approval timelines, can also affect the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can limit the flexibility of participants within the ecosystem. The somatic genetic testing ecosystem may differ by region due to variations in regulatory frameworks, healthcare infrastructure, and market demand, highlighting the need for a nuanced understanding of these regional differences to navigate the ecosystem effectively.

Recent Industry Insights

The somatic genetic testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between leading biotechnology firms and research institutions, have driven innovation in the field. Notable mergers and acquisitions have also taken place, with companies expanding their portfolios to include somatic genetic testing solutions. Furthermore, several product and technology launches have been announced, showcasing advancements in non-invasive testing methods and artificial intelligence-powered diagnostics.

Additionally, regulatory changes have been implemented to ensure the safe and effective use of somatic genetic testing. A shift in consumer and enterprise trends has also been observed, with increasing demand for personalized medicine and targeted therapies. Funding rounds and expansions have been secured by several companies, enabling them to further invest in research and development. These developments are expected to continue shaping the somatic genetic testing industry trends in the coming years.

Analyst Overview

As the Lead Analyst for this study, my expert view on the somatic genetic testing market is that it presents a highly attractive opportunity for growth, driven by increasing demand for personalized medicine and advancements in genetic sequencing technologies. The somatic genetic testing market outlook is promising, with a growing need for non-invasive diagnostic tests. However, the competitive intensity is moderate, with several key players vying for market share.

The long-term outlook for this market is positive, with innovations in next-generation sequencing and artificial intelligence expected to drive growth. The demand-supply balance is currently skewed towards demand, with key risk factors including regulatory uncertainties and high development costs. Overall, the somatic genetic testing market is poised for significant expansion, driven by its potential to transform the field of genetics and improve patient outcomes.

11 items

1. Executive Summary

2. somatic genetic testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global somatic genetic testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global somatic genetic testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic and Research Institutions

6.1.2. Hospitals and Diagnostic Laboratories

6.1.3. Pharmaceutical and Biotechnology Companies

6.1.4. Contract Research Organizations

6.1.5. Others

6.2. Global somatic genetic testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Product (Kits and Assays, Instruments, and Software)

6.2.2. Services

6.3. Global somatic genetic testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global somatic genetic testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global somatic genetic testing Market by: Regions (Value)

8. Global somatic genetic testing Market Competition by Key Manufacturers

8.1. Global somatic genetic testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global somatic genetic testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Agilent Technologies, Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ARUP Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ASURAGEN INC

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Beijing Genomics Institute (BGI) Genomics Co.,Ltd

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. bioMérieux S.A.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. CENTOGENE N.V

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. CIRCULOGENE Theranostics, LLC

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. F. Hoffmann-La Roche Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Guardant Health, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Illumina, Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Invivoscribe, Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Laboratory Corporation of America Holdings

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Mission Bio

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. NeoGenomics Laboratories, Inc.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. OmniSeq

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Oxford Nanopore Technologies, Ltd.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Pacific Biosciences of California, Inc.

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. QIAGEN N.V.

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Quest Diagnostics Incorporated

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Thermo Fisher Scientific Inc.

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global somatic genetic testing Market

Figure 4: Global somatic genetic testing Market: Drivers

Figure 5: Global somatic genetic testing Market: Challenges

Figure 6: Global somatic genetic testing Market: Trends

Figure 7: Global somatic genetic testing Market: Opportunity

Figure 8: Global somatic genetic testing Market: Restraint

Figure 9: Global somatic genetic testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global somatic genetic testing Market Value (USD Million) By Region

Figure 15: Global somatic genetic testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global somatic genetic testing Market Value (USD Million) By Region

Figure 23: Global somatic genetic testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global somatic genetic testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global somatic genetic testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global somatic genetic testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global somatic genetic testing Market Value (USD Million) By Region

Table 10: Global somatic genetic testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global somatic genetic testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global somatic genetic testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global somatic genetic testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Agilent Technologies, Inc. Basic Information And Sales Area

Table 31: Agilent Technologies, Inc.. Products Portfolio

Table 32: ARUP Laboratories Basic Information And Sales Area

Table 33: ARUP Laboratories. Products Portfolio

Table 34: ASURAGEN INC Basic Information And Sales Area

Table 35: ASURAGEN INC. Products Portfolio

Table 36: Beijing Genomics Institute (BGI) Genomics Co.,Ltd Basic Information And Sales Area

Table 37: Beijing Genomics Institute (BGI) Genomics Co.,Ltd. Products Portfolio

Table 38: bioMérieux S.A. Basic Information And Sales Area

Table 39: bioMérieux S.A.. Products Portfolio

Table 40: CENTOGENE N.V Basic Information And Sales Area

Table 41: CENTOGENE N.V. Products Portfolio

Table 42: CIRCULOGENE Theranostics, LLC Basic Information And Sales Area

Table 43: CIRCULOGENE Theranostics, LLC. Products Portfolio

Table 44: F. Hoffmann-La Roche Ltd. Basic Information And Sales Area

Table 45: F. Hoffmann-La Roche Ltd.. Products Portfolio

Table 46: Guardant Health, Inc. Basic Information And Sales Area

Table 47: Guardant Health, Inc.. Products Portfolio

Table 48: Illumina, Inc. Basic Information And Sales Area

Table 49: Illumina, Inc.. Products Portfolio

Table 50: Invivoscribe, Inc. Basic Information And Sales Area

Table 51: Invivoscribe, Inc.. Products Portfolio

Table 52: Laboratory Corporation of America Holdings Basic Information And Sales Area

Table 53: Laboratory Corporation of America Holdings. Products Portfolio

Table 54: Mission Bio Basic Information And Sales Area

Table 55: Mission Bio. Products Portfolio

Table 56: NeoGenomics Laboratories, Inc. Basic Information And Sales Area

Table 57: NeoGenomics Laboratories, Inc.. Products Portfolio

Table 58: OmniSeq Basic Information And Sales Area

Table 59: OmniSeq. Products Portfolio

Table 60: Oxford Nanopore Technologies, Ltd. Basic Information And Sales Area

Table 61: Oxford Nanopore Technologies, Ltd.. Products Portfolio

Table 62: Pacific Biosciences of California, Inc. Basic Information And Sales Area

Table 63: Pacific Biosciences of California, Inc.. Products Portfolio

Table 64: QIAGEN N.V. Basic Information And Sales Area

Table 65: QIAGEN N.V.. Products Portfolio

Table 66: Quest Diagnostics Incorporated Basic Information And Sales Area

Table 67: Quest Diagnostics Incorporated. Products Portfolio

Table 68: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 69: Thermo Fisher Scientific Inc.. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global somatic genetic testing Market Value (USD Million) By Region

Table 75: Global somatic genetic testing Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

somatic genetic testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	37.22 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Agilent Technologies, Inc.; ARUP Laboratories; ASURAGEN INC; Beijing Genomics Institute (BGI) Genomics Co.,Ltd; bioMérieux S.A.; CENTOGENE N.V; CIRCULOGENE Theranostics, LLC; F. Hoffmann-La Roche Ltd.; Guardant Health, Inc.; Illumina, Inc.; Invivoscribe, Inc.; Laboratory Corporation of America Holdings; Mission Bio; NeoGenomics Laboratories, Inc.; OmniSeq; Oxford Nanopore Technologies, Ltd.; Pacific Biosciences of California, Inc.; QIAGEN N.V.; Quest Diagnostics Incorporated; Thermo Fisher Scientific Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

somatic genetic testing Segmentation Breakdown9 items

Application

Academic and Research Institutions

Hospitals and Diagnostic Laboratories

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Others

Types

Product (Kits and Assays, Instruments, and Software)

Services

Regional Insights

Loading chart…

Competitive Landscape

Agilent Technologies, Inc. - regional expansion

ARUP Laboratories - vertical integration

ASURAGEN INC - premium pricing

Beijing Genomics Institute (BGI) - innovation pipeline

bioMérieux S.A. - local manufacturing

CENTOGENE N.V - OEM tie-ups

Key somatic genetic testing Companies20 items

Agilent Technologies, Inc.

ARUP Laboratories

ASURAGEN INC

Beijing Genomics Institute (BGI) Genomics Co.,Ltd

bioMérieux S.A.

CENTOGENE N.V

CIRCULOGENE Theranostics, LLC

F. Hoffmann-La Roche Ltd.

Guardant Health, Inc.

Illumina, Inc.

Invivoscribe, Inc.

Laboratory Corporation of America Holdings

Mission Bio

NeoGenomics Laboratories, Inc.

OmniSeq

Oxford Nanopore Technologies, Ltd.

Pacific Biosciences of California, Inc.

QIAGEN N.V.

Quest Diagnostics Incorporated

Thermo Fisher Scientific Inc.

Market Ecosystem

Raw material suppliers — providing genetic testing reagents

Technology providers — developing genetic testing platforms

OEMs/manufacturers — producing testing equipment and kits

System integrators — configuring testing systems for laboratories

Distributors/channel partners — supplying testing products to end users

Service providers — offering testing and analysis services

Regulators/standards bodies — establishing testing standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents